wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q36484581-467A8413-3F70-43F2-9528-ED757D8FEC10
Q36484581-467A8413-3F70-43F2-9528-ED757D8FEC10
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36484581-467A8413-3F70-43F2-9528-ED757D8FEC10
Randomised phase II trial of irinotecan plus cisplatin vs irinotecan, cisplatin plus etoposide repeated every 3 weeks in patients with extensive-disease small-cell lung cancer.
P2860
Q36484581-467A8413-3F70-43F2-9528-ED757D8FEC10
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36484581-467A8413-3F70-43F2-9528-ED757D8FEC10
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
f1d5f4d00229079832e8c0d5e6c78fe3c2eac21c
P2860
Irinotecan plus cisplatin compared with etoposide plus cisplatin for extensive small-cell lung cancer.